DPT Laboratories has announced plans to restructure its facilities, creating three new Centers of Excellence, each focusing on a different area of expertise: Sterile & Specialty Products, Semi-solids & Liquids, and R&D.

“We feel each of these Centers of Excellence will provide our clients with access to experienced personnel who are experts in their field and who will provide comprehensive development and manufacturing services,” said Paul Johnson, president and chief operating officer of DPT.

DPT Laboratories in Lakewood, NJ is home to The Center for Sterile & Specialty Products. This center specializes in development and aseptic manufacturing of clinical trial material and commercial scale products to meet sterile requirements. The 175,000-sq.-ft. site recently underwent a multimillion-dollar transformation to provide state-of-the-art aseptic processing suites and filling equipment.

The Center for Semi-solids & Liquids in San Antonio, TX will provide cGMP pilot, clinical and commercial scale manufacturing for prescription and OTC products. The center also includes a dedicated cGMP aerosol and pMDI manufacturing facility. A multi-million-dollar investment was also made to this center to improve efficiency and increase capacity.

DPT’s Center for R&D in San Antonio provides pharmaceutical development services to include pre-formulation and formulation development as well as analytical development services. This center will perform R&D activities and support technical transfers to the applicable manufacturing center of excellence.

“We are committed to excellence and investing in our future. Our goal is to provide our clients the most efficient and the best development and manufacturing services,” said Mr. Johnson. “These strategic changes reflect our mission of providing enhancements to service, innovation, and technology for our customers as we move into our next strategic plan.”